Physician profile
Alexa Westerbeck
NPI 1912484445
$3,111.15
in general payments reported to CMS, 2019-2025
9 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,186 · 2020: $1,219 · 2021: $222 · 2022: $129 · 2023: $46.18 · 2024: $125 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,405.23 | 2019-2025 | Tryptyr, Rocklatan |
| Valley Contax, INC. | $1,139.01 | 2019 | |
| Visioneering Technologies, INC. | $221.92 | 2021 | |
| Oyster Point Pharma, INC. | $196.43 | 2022-2025 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $43.78 | 2022-2023 | Durysta |
| Kala Pharmaceuticals, INC. | $35.21 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $27.32 | 2019 | |
| Allergan, INC. | $24.04 | 2022 | |
| Bausch & Lomb Americas INC. | $18.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Westerbeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.